NCT01852591 · OUTCOME
CD8+CTV-IFN-gamma+, Best Response Against Vaccine (CRM 197)
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- NUMBER
- Unit
- percentage of CD8 cells
- Interval / dispersion
- Not reported
- Time frame
- 30 Days Post Vaccine
What was measured
Best CD8+ response against CRM197 at day +30 after transplant, utilizing flow cytometry for interferon-γ (IFN-gamma). Peripheral blood mononuclear cells were stained with cell trace violet then incubated with CRM197 or vehicle control. Cells were then harvested and stained for flow cytometry. Highest percentage increase of CD8 cells from pre-vaccine to Day + 30.
Analysis population: All evaluable participants.
Groups in this outcome
Experimental: PCV 13
Pneumococcal conjugate vaccine (PCV 13), 0.5ml, 3 to 30 days prior to transplant and then again at 7-10 and 21-24 days after transplant.
| Group | Source count |
|---|---|
| Experimental: PCV 13 | 5 |
Reported measurements
Highest % of CD8 cells Pre-vaccine
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Experimental: PCV 13 | 0.00 | Not reported | Not reported | Not reported | Not reported |
Best Response % of CD8 cells Day +30
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Experimental: PCV 13 | 2.69 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- value
- 0.00
- title
- Highest % of CD8 cells Pre-vaccine
- categories
- measurements
- group Id
- OG000
- value
- 2.69
- title
- Best Response % of CD8 cells Day +30
- denoms
- counts
- group Id
- OG000
- value
- 5
- units
- Participants
- description
- Best CD8+ response against CRM197 at day +30 after transplant, utilizing flow cytometry for interferon-γ (IFN-gamma). Peripheral blood mononuclear cells were stained with cell trace violet then incubated with CRM197 or vehicle control. Cells were then harvested and stained for flow cytometry. Highest percentage increase of CD8 cells from pre-vaccine to Day + 30.
- groups
- description
- Pneumococcal conjugate vaccine (PCV 13), 0.5ml, 3 to 30 days prior to transplant and then again at 7-10 and 21-24 days after transplant.
- id
- OG000
- title
- Experimental: PCV 13
- param Type
- NUMBER
- population Description
- All evaluable participants.
- reporting Status
- POSTED
- time Frame
- 30 Days Post Vaccine
- title
- CD8+CTV-IFN-gamma+, Best Response Against Vaccine (CRM 197)
- type
- SECONDARY
- unit Of Measure
- percentage of CD8 cells
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle